XEROX HOLDINGS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues
Total Revenues	$ 1,528	$ 1,652	$ 4,608	$ 5,121
Costs and Expenses
Cost of financing	26	30	82	100
Research, development and engineering expenses	45	52	144	173
Selling, administrative and general expenses	370	416	1,160	1,256
Goodwill impairment	1,058	0	1,058	0
Restructuring and related costs, net	56	10	107	35
Amortization of intangible assets	10	12	30	33
Divestitures	0	0	51	0
PARC Donation	0	0	0	132
Other expenses, net	43	(18)	120	33
Total Costs and Expenses	2,615	1,588	5,820	5,061
(Loss) Income before Income Taxes	(1,087)	64	(1,212)	60
Income tax expense	118	15	88	1
Net (Loss) Income	(1,205)	49	(1,300)	59
Less: Preferred stock dividends, net	(4)	(4)	(11)	(11)
Net (Loss) Income Attributable to Common Shareholders	$ (1,209)	$ 45	$ (1,311)	$ 48
Basic (Loss) Earnings per Share (in dollars per share)	$ (9.71)	$ 0.29	$ (10.55)	$ 0.31
Diluted (Loss) Earnings per Share (in dollars per share)	$ (9.71)	$ 0.28	$ (10.55)	$ 0.30
Sales
Revenues
Total Revenues	$ 588	$ 644	$ 1,722	$ 1,999
Costs and Expenses
Cost of sales/services, maintenance and rentals	390	435	1,117	1,312
Services, maintenance and rentals
Revenues
Total Revenues	902	962	2,768	2,975
Costs and Expenses
Cost of sales/services, maintenance and rentals	617	651	1,951	1,987
Financing
Revenues
Total Revenues	$ 38	$ 46	$ 118	$ 147